abstract |
The present invention describes antibodies that interact with interleukin-1 receptor type 1 (IL-1R1). The present invention also describes a method for treating an IL-1 mediated disease by administering a pharmaceutically effective amount of an antibody against IL-1R1 and a method for detecting the amount of IL-1R1 in a sample using an antibody against IL-1R1. Doing. |